The import of veterinary vaccines to the US is projected to increase steadily over the next five years, growing from $17.913 million in 2024 to $20.509 million in 2028. Given that the import value for 2023 is not provided, it is assumed that the 2024 forecast begins this new evaluation period. The year-on-year growth is consistent, demonstrating confidence in the continued demand and reliance on veterinary vaccines, excluding foot and mouth disease.
Looking forward, trends to watch include potential disruptions from global supply chain challenges, regulatory changes, and innovations in veterinary healthcare. Additionally, shifts in animal health management and biosecurity priorities could significantly influence future import needs.
